Entera Bio Ltd

Entera Bio Ltd Stock

—P/E
€520.61MMarket capitalisation
-US$0.40Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Entera Bio Ltd is registered in the following country: Israel (Exchange: USNASD).

Key metrics

Key metrics and master data for the Entera Bio Ltd stock.

Market capitalisation
€520.61M
P/E
—
P/B
2.01
P/S
1,428.57
P/CF
-14.56
Issued shares 174M Units

Return

Here you can see the performance of the Entera Bio Ltd stock.

PeriodPerfor­mance
1 Week+2.86 %
1 Month+24.14 %
3 Months+19.01 %
6 Months+179.61 %
1 Year+28.57 %
YTD+93.55 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Entera Bio Ltd share.

DateRatio
No data available.

Which ETF contains the Entera Bio Ltd stock?

The Entera Bio Ltd stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Entera Bio Ltd has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Entera Bio Ltd stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.